Tags

Type your tag names separated by a space and hit enter

[Predictors of smoking cessation in group-based behavioral intervention programme--research findings in 2001-2007].
Przegl Lek. 2008; 65(10):634-40.PL

Abstract

The efficacy and cost-effectiveness of behavioral treatments compare favorably with the pharmacotherapies and community-based interventions. Group-based behavioral programmes have been scientifically proven as the effective smoking cessation intervention. Identifying predictors of the efficacy of smoking cessation within group-based programme using characteristics of participants (social and environmental approach). Program is a multicomponent group-based behavioral intervention with the elements recommended by the US Public Health Service as the most effective. 517 smokers were included into the program in the outpatient clinic setting in years 2001-2007. A point prevalence abstinence (PPA) was estimated by self-reported smoking cessation. 59.% of participants stopped smoking during four-week program. Using multivariate logistic regression, a model provided the optimal predictive ability. PPA decreased (odds ratio [OR], 0.7; 95% confidence interval [CI], 0.24-0.93) for manual occupied and unemployed participant comparing to nonmanual occupied smoker, decreased (OR, 0.9; 95% CI, 0.20-1.19) for high-nicotine-dependent smoker, increased (OR, 1.49; 95% CI, 0.74-2.98) for high-motivated to quit smoking participant, increased (OR 2.31; 95% CI, 1.15-4.66) for subject smoked 1 pack or more of cigarettes per day, decreased (OR 1.41; 95% CI, 0.85-2.35) for participant with smoker in household, decreased (OR 1.74; 95% CI, 1.09-2.78) for smoker without any previous physician's advice to quit and did not distinguish for subject without any previous attempts. The future of behavioral group-based treatment will likely emphasize intensive intervention targeted to particular subgroups of smokers with the need and motivation for them (eg, the low nicotine-dependent but with high emotional and/or behavioral components of dependency, poor supported by family and non-medical patients). A blurring of the distinctions between behavioral interventions, pharmacotherapies, and community-oriented approaches is also likely as multidimensional cessation strategies are developed.

Authors+Show Affiliations

Katedra Medycyny Społecznej i Zapobiegawczej, Uniwersytet Medyczny w Łodzi. office@cindi.org.plNo affiliation info availableNo affiliation info available

Pub Type(s)

Evaluation Study
Journal Article

Language

pol

PubMed ID

19189567

Citation

Broszkiewicz, Marzenna, et al. "[Predictors of Smoking Cessation in Group-based Behavioral Intervention Programme--research Findings in 2001-2007]." Przeglad Lekarski, vol. 65, no. 10, 2008, pp. 634-40.
Broszkiewicz M, Sobala W, Drygas W. [Predictors of smoking cessation in group-based behavioral intervention programme--research findings in 2001-2007]. Przegl Lek. 2008;65(10):634-40.
Broszkiewicz, M., Sobala, W., & Drygas, W. (2008). [Predictors of smoking cessation in group-based behavioral intervention programme--research findings in 2001-2007]. Przeglad Lekarski, 65(10), 634-40.
Broszkiewicz M, Sobala W, Drygas W. [Predictors of Smoking Cessation in Group-based Behavioral Intervention Programme--research Findings in 2001-2007]. Przegl Lek. 2008;65(10):634-40. PubMed PMID: 19189567.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Predictors of smoking cessation in group-based behavioral intervention programme--research findings in 2001-2007]. AU - Broszkiewicz,Marzenna, AU - Sobala,Wojciech, AU - Drygas,Wojciech, PY - 2009/2/5/entrez PY - 2009/2/5/pubmed PY - 2009/3/18/medline SP - 634 EP - 40 JF - Przeglad lekarski JO - Przegl Lek VL - 65 IS - 10 N2 - The efficacy and cost-effectiveness of behavioral treatments compare favorably with the pharmacotherapies and community-based interventions. Group-based behavioral programmes have been scientifically proven as the effective smoking cessation intervention. Identifying predictors of the efficacy of smoking cessation within group-based programme using characteristics of participants (social and environmental approach). Program is a multicomponent group-based behavioral intervention with the elements recommended by the US Public Health Service as the most effective. 517 smokers were included into the program in the outpatient clinic setting in years 2001-2007. A point prevalence abstinence (PPA) was estimated by self-reported smoking cessation. 59.% of participants stopped smoking during four-week program. Using multivariate logistic regression, a model provided the optimal predictive ability. PPA decreased (odds ratio [OR], 0.7; 95% confidence interval [CI], 0.24-0.93) for manual occupied and unemployed participant comparing to nonmanual occupied smoker, decreased (OR, 0.9; 95% CI, 0.20-1.19) for high-nicotine-dependent smoker, increased (OR, 1.49; 95% CI, 0.74-2.98) for high-motivated to quit smoking participant, increased (OR 2.31; 95% CI, 1.15-4.66) for subject smoked 1 pack or more of cigarettes per day, decreased (OR 1.41; 95% CI, 0.85-2.35) for participant with smoker in household, decreased (OR 1.74; 95% CI, 1.09-2.78) for smoker without any previous physician's advice to quit and did not distinguish for subject without any previous attempts. The future of behavioral group-based treatment will likely emphasize intensive intervention targeted to particular subgroups of smokers with the need and motivation for them (eg, the low nicotine-dependent but with high emotional and/or behavioral components of dependency, poor supported by family and non-medical patients). A blurring of the distinctions between behavioral interventions, pharmacotherapies, and community-oriented approaches is also likely as multidimensional cessation strategies are developed. SN - 0033-2240 UR - https://www.unboundmedicine.com/medline/citation/19189567/[Predictors_of_smoking_cessation_in_group_based_behavioral_intervention_programme__research_findings_in_2001_2007]_ L2 - https://medlineplus.gov/quittingsmoking.html DB - PRIME DP - Unbound Medicine ER -